nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—ABCG2—hematologic cancer	0.184	0.706	CbGaD
Rilpivirine—ABCB1—hematologic cancer	0.0765	0.294	CbGaD
Rilpivirine—ABCG2—Clofarabine—hematologic cancer	0.0299	0.057	CbGbCtD
Rilpivirine—CYP1A2—Anagrelide—hematologic cancer	0.0178	0.0339	CbGbCtD
Rilpivirine—ABCG2—Daunorubicin—hematologic cancer	0.0176	0.0334	CbGbCtD
Rilpivirine—CYP2B6—Thiotepa—hematologic cancer	0.0175	0.0332	CbGbCtD
Rilpivirine—ABCG2—Teniposide—hematologic cancer	0.0153	0.029	CbGbCtD
Rilpivirine—ABCG2—Cladribine—hematologic cancer	0.0146	0.0278	CbGbCtD
Rilpivirine—ABCG2—Imatinib—hematologic cancer	0.0134	0.0256	CbGbCtD
Rilpivirine—ABCG2—Nilotinib—hematologic cancer	0.0122	0.0233	CbGbCtD
Rilpivirine—ABCG2—Dasatinib—hematologic cancer	0.0108	0.0206	CbGbCtD
Rilpivirine—ABCB1—Lenalidomide—hematologic cancer	0.0108	0.0205	CbGbCtD
Rilpivirine—ABCG2—Mitoxantrone—hematologic cancer	0.0107	0.0203	CbGbCtD
Rilpivirine—SLCO1B1—Irinotecan—hematologic cancer	0.0106	0.0201	CbGbCtD
Rilpivirine—CYP2B6—Ifosfamide—hematologic cancer	0.0099	0.0188	CbGbCtD
Rilpivirine—SLCO1B3—Methotrexate—hematologic cancer	0.00961	0.0183	CbGbCtD
Rilpivirine—CYP1A2—Carmustine—hematologic cancer	0.00936	0.0178	CbGbCtD
Rilpivirine—CYP2B6—Nilotinib—hematologic cancer	0.00859	0.0164	CbGbCtD
Rilpivirine—ABCG2—Irinotecan—hematologic cancer	0.0084	0.016	CbGbCtD
Rilpivirine—CYP2C19—Bortezomib—hematologic cancer	0.0082	0.0156	CbGbCtD
Rilpivirine—CYP1A2—Methoxsalen—hematologic cancer	0.00796	0.0151	CbGbCtD
Rilpivirine—CYP1A2—Bortezomib—hematologic cancer	0.00757	0.0144	CbGbCtD
Rilpivirine—ABCG2—Vincristine—hematologic cancer	0.00734	0.014	CbGbCtD
Rilpivirine—CYP1A2—Daunorubicin—hematologic cancer	0.00724	0.0138	CbGbCtD
Rilpivirine—CYP2C19—Thalidomide—hematologic cancer	0.00715	0.0136	CbGbCtD
Rilpivirine—CYP1A2—Alitretinoin—hematologic cancer	0.00709	0.0135	CbGbCtD
Rilpivirine—ABCG2—Cisplatin—hematologic cancer	0.00685	0.013	CbGbCtD
Rilpivirine—CYP2C19—Teniposide—hematologic cancer	0.00682	0.013	CbGbCtD
Rilpivirine—ABCG2—Etoposide—hematologic cancer	0.00673	0.0128	CbGbCtD
Rilpivirine—CYP1A2—Thalidomide—hematologic cancer	0.00659	0.0125	CbGbCtD
Rilpivirine—CYP3A4—Bexarotene—hematologic cancer	0.00647	0.0123	CbGbCtD
Rilpivirine—ABCB1—Daunorubicin—hematologic cancer	0.00633	0.012	CbGbCtD
Rilpivirine—CYP2C19—Ifosfamide—hematologic cancer	0.00629	0.012	CbGbCtD
Rilpivirine—ABCB1—Alitretinoin—hematologic cancer	0.0062	0.0118	CbGbCtD
Rilpivirine—CYP3A4—Lomustine—hematologic cancer	0.00601	0.0114	CbGbCtD
Rilpivirine—CYP3A4—Busulfan—hematologic cancer	0.00601	0.0114	CbGbCtD
Rilpivirine—CYP2C19—Imatinib—hematologic cancer	0.00601	0.0114	CbGbCtD
Rilpivirine—CYP2B6—Irinotecan—hematologic cancer	0.00591	0.0112	CbGbCtD
Rilpivirine—CYP1A2—Dacarbazine—hematologic cancer	0.00567	0.0108	CbGbCtD
Rilpivirine—SLCO1B1—Methotrexate—hematologic cancer	0.0056	0.0106	CbGbCtD
Rilpivirine—CYP1A2—Imatinib—hematologic cancer	0.00554	0.0106	CbGbCtD
Rilpivirine—ABCG2—Dexamethasone—hematologic cancer	0.00553	0.0105	CbGbCtD
Rilpivirine—CYP3A4—Thiotepa—hematologic cancer	0.00536	0.0102	CbGbCtD
Rilpivirine—ABCB1—Imatinib—hematologic cancer	0.00485	0.00923	CbGbCtD
Rilpivirine—CYP2B6—Cisplatin—hematologic cancer	0.00482	0.00916	CbGbCtD
Rilpivirine—ABCG2—Doxorubicin—hematologic cancer	0.00459	0.00873	CbGbCtD
Rilpivirine—CYP1A2—Dasatinib—hematologic cancer	0.00445	0.00847	CbGbCtD
Rilpivirine—ABCG2—Methotrexate—hematologic cancer	0.00444	0.00846	CbGbCtD
Rilpivirine—ABCB1—Nilotinib—hematologic cancer	0.00441	0.00838	CbGbCtD
Rilpivirine—ABCB1—Vinorelbine—hematologic cancer	0.00437	0.00831	CbGbCtD
Rilpivirine—CYP3A4—Methoxsalen—hematologic cancer	0.00417	0.00793	CbGbCtD
Rilpivirine—CYP3A4—Bortezomib—hematologic cancer	0.00397	0.00754	CbGbCtD
Rilpivirine—CYP2C19—Prednisone—hematologic cancer	0.00396	0.00753	CbGbCtD
Rilpivirine—ABCB1—Dasatinib—hematologic cancer	0.00389	0.00741	CbGbCtD
Rilpivirine—CYP2B6—Dexamethasone—hematologic cancer	0.00389	0.0074	CbGbCtD
Rilpivirine—ABCB1—Mitoxantrone—hematologic cancer	0.00385	0.00732	CbGbCtD
Rilpivirine—CYP3A4—Daunorubicin—hematologic cancer	0.00379	0.00722	CbGbCtD
Rilpivirine—ABCB1—Betamethasone—hematologic cancer	0.00343	0.00652	CbGbCtD
Rilpivirine—ABCB1—Gemcitabine—hematologic cancer	0.0034	0.00647	CbGbCtD
Rilpivirine—ABCB1—Prednisolone—hematologic cancer	0.00338	0.00644	CbGbCtD
Rilpivirine—CYP3A4—Cytarabine—hematologic cancer	0.00335	0.00637	CbGbCtD
Rilpivirine—CYP3A4—Teniposide—hematologic cancer	0.0033	0.00627	CbGbCtD
Rilpivirine—CYP2B6—Doxorubicin—hematologic cancer	0.00323	0.00614	CbGbCtD
Rilpivirine—ABCB1—Prednisone—hematologic cancer	0.00319	0.00608	CbGbCtD
Rilpivirine—CYP3A4—Ifosfamide—hematologic cancer	0.00304	0.00579	CbGbCtD
Rilpivirine—ABCB1—Irinotecan—hematologic cancer	0.00303	0.00576	CbGbCtD
Rilpivirine—CYP3A4—Imatinib—hematologic cancer	0.00291	0.00553	CbGbCtD
Rilpivirine—CYP1A2—Etoposide—hematologic cancer	0.00277	0.00528	CbGbCtD
Rilpivirine—CYP3A4—Ruxolitinib—hematologic cancer	0.00274	0.00521	CbGbCtD
Rilpivirine—ABCB1—Vinblastine—hematologic cancer	0.00269	0.00512	CbGbCtD
Rilpivirine—ABCB1—Vincristine—hematologic cancer	0.00265	0.00504	CbGbCtD
Rilpivirine—CYP3A4—Nilotinib—hematologic cancer	0.00264	0.00502	CbGbCtD
Rilpivirine—CYP3A4—Vinorelbine—hematologic cancer	0.00262	0.00498	CbGbCtD
Rilpivirine—CYP2C19—Dexamethasone—hematologic cancer	0.00247	0.0047	CbGbCtD
Rilpivirine—ABCB1—Cisplatin—hematologic cancer	0.00247	0.0047	CbGbCtD
Rilpivirine—ABCB1—Etoposide—hematologic cancer	0.00243	0.00462	CbGbCtD
Rilpivirine—CYP3A4—Triamcinolone—hematologic cancer	0.00239	0.00456	CbGbCtD
Rilpivirine—CYP3A4—Dasatinib—hematologic cancer	0.00233	0.00444	CbGbCtD
Rilpivirine—CYP3A4—Mitoxantrone—hematologic cancer	0.0023	0.00439	CbGbCtD
Rilpivirine—CYP3A4—Betamethasone—hematologic cancer	0.00205	0.00391	CbGbCtD
Rilpivirine—CYP3A4—Prednisolone—hematologic cancer	0.00203	0.00386	CbGbCtD
Rilpivirine—ABCB1—Dexamethasone—hematologic cancer	0.00199	0.00379	CbGbCtD
Rilpivirine—CYP3A4—Prednisone—hematologic cancer	0.00191	0.00364	CbGbCtD
Rilpivirine—CYP3A4—Irinotecan—hematologic cancer	0.00181	0.00345	CbGbCtD
Rilpivirine—ABCB1—Doxorubicin—hematologic cancer	0.00165	0.00315	CbGbCtD
Rilpivirine—CYP3A4—Vinblastine—hematologic cancer	0.00161	0.00307	CbGbCtD
Rilpivirine—ABCB1—Methotrexate—hematologic cancer	0.0016	0.00305	CbGbCtD
Rilpivirine—CYP3A4—Vincristine—hematologic cancer	0.00159	0.00302	CbGbCtD
Rilpivirine—CYP3A4—Etoposide—hematologic cancer	0.00145	0.00277	CbGbCtD
Rilpivirine—CYP3A4—Dexamethasone—hematologic cancer	0.00119	0.00227	CbGbCtD
Rilpivirine—CYP3A4—Doxorubicin—hematologic cancer	0.000991	0.00189	CbGbCtD
Rilpivirine—Pazopanib—SH2B3—hematologic cancer	0.000986	0.157	CrCbGaD
Rilpivirine—Pazopanib—LCK—hematologic cancer	0.00094	0.15	CrCbGaD
Rilpivirine—Pazopanib—FGF1—hematologic cancer	0.000838	0.134	CrCbGaD
Rilpivirine—Pazopanib—FGFR3—hematologic cancer	0.000788	0.126	CrCbGaD
Rilpivirine—Pazopanib—CSF1R—hematologic cancer	0.000566	0.0905	CrCbGaD
Rilpivirine—Pazopanib—PDGFRB—hematologic cancer	0.000494	0.0789	CrCbGaD
Rilpivirine—Pazopanib—PDGFRA—hematologic cancer	0.000481	0.0769	CrCbGaD
Rilpivirine—Pazopanib—KIT—hematologic cancer	0.000353	0.0565	CrCbGaD
Rilpivirine—Pazopanib—UGT1A1—hematologic cancer	0.000348	0.0556	CrCbGaD
Rilpivirine—SLCO1B3—lung—hematologic cancer	0.00033	0.0984	CbGeAlD
Rilpivirine—SLCO1B1—hematopoietic system—hematologic cancer	0.000329	0.098	CbGeAlD
Rilpivirine—SLCO1B1—blood—hematologic cancer	0.000218	0.0649	CbGeAlD
Rilpivirine—CYP2C19—hematopoietic system—hematologic cancer	0.000214	0.0638	CbGeAlD
Rilpivirine—Pazopanib—ABCG2—hematologic cancer	0.000196	0.0313	CrCbGaD
Rilpivirine—Etravirine—ABCB1—hematologic cancer	0.000187	0.0299	CrCbGaD
Rilpivirine—CYP1A2—hematopoietic system—hematologic cancer	0.000175	0.0521	CbGeAlD
Rilpivirine—CYP2B6—hematopoietic system—hematologic cancer	0.000168	0.05	CbGeAlD
Rilpivirine—CYP2C19—blood—hematologic cancer	0.000142	0.0423	CbGeAlD
Rilpivirine—CYP2B6—gonad—hematologic cancer	0.000127	0.038	CbGeAlD
Rilpivirine—CYP3A4—hematopoietic system—hematologic cancer	0.000127	0.0377	CbGeAlD
Rilpivirine—ABCG2—blood—hematologic cancer	0.00012	0.0359	CbGeAlD
Rilpivirine—ABCG2—bone marrow—hematologic cancer	0.000117	0.0347	CbGeAlD
Rilpivirine—CYP1A2—blood—hematologic cancer	0.000116	0.0345	CbGeAlD
Rilpivirine—CYP2B6—blood—hematologic cancer	0.000111	0.0331	CbGeAlD
Rilpivirine—ABCG2—lung—hematologic cancer	0.000106	0.0315	CbGeAlD
Rilpivirine—CYP1A2—lung—hematologic cancer	0.000102	0.0303	CbGeAlD
Rilpivirine—ABCG2—testis—hematologic cancer	9.96e-05	0.0297	CbGeAlD
Rilpivirine—CYP2B6—lung—hematologic cancer	9.74e-05	0.029	CbGeAlD
Rilpivirine—CYP2B6—testis—hematologic cancer	9.19e-05	0.0274	CbGeAlD
Rilpivirine—ABCB1—hematopoietic system—hematologic cancer	8.96e-05	0.0267	CbGeAlD
Rilpivirine—CYP3A4—blood—hematologic cancer	8.39e-05	0.025	CbGeAlD
Rilpivirine—Pazopanib—ABCB1—hematologic cancer	8.14e-05	0.013	CrCbGaD
Rilpivirine—ABCG2—lymph node—hematologic cancer	7.22e-05	0.0215	CbGeAlD
Rilpivirine—ABCB1—gonad—hematologic cancer	6.81e-05	0.0203	CbGeAlD
Rilpivirine—ABCB1—blood—hematologic cancer	5.94e-05	0.0177	CbGeAlD
Rilpivirine—ABCB1—bone marrow—hematologic cancer	5.74e-05	0.0171	CbGeAlD
Rilpivirine—ABCB1—lung—hematologic cancer	5.2e-05	0.0155	CbGeAlD
Rilpivirine—Rash—Bleomycin—hematologic cancer	5.08e-05	0.00034	CcSEcCtD
Rilpivirine—Dermatitis—Bleomycin—hematologic cancer	5.07e-05	0.00034	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Doxorubicin—hematologic cancer	5.06e-05	0.000339	CcSEcCtD
Rilpivirine—Asthenia—Carmustine—hematologic cancer	5.04e-05	0.000338	CcSEcCtD
Rilpivirine—Vomiting—Vinorelbine—hematologic cancer	5.04e-05	0.000337	CcSEcCtD
Rilpivirine—Dry mouth—Triamcinolone—hematologic cancer	5.03e-05	0.000337	CcSEcCtD
Rilpivirine—Renal failure—Methotrexate—hematologic cancer	5.02e-05	0.000336	CcSEcCtD
Rilpivirine—Diarrhoea—Thalidomide—hematologic cancer	5.01e-05	0.000335	CcSEcCtD
Rilpivirine—Dizziness—Thiotepa—hematologic cancer	5e-05	0.000335	CcSEcCtD
Rilpivirine—Asthenia—Alitretinoin—hematologic cancer	5e-05	0.000334	CcSEcCtD
Rilpivirine—Rash—Vinorelbine—hematologic cancer	5e-05	0.000334	CcSEcCtD
Rilpivirine—Dermatitis—Vinorelbine—hematologic cancer	4.99e-05	0.000334	CcSEcCtD
Rilpivirine—Headache—Vinorelbine—hematologic cancer	4.96e-05	0.000332	CcSEcCtD
Rilpivirine—Immune system disorder—Prednisone—hematologic cancer	4.95e-05	0.000332	CcSEcCtD
Rilpivirine—Asthenia—Ifosfamide—hematologic cancer	4.94e-05	0.000331	CcSEcCtD
Rilpivirine—ABCB1—testis—hematologic cancer	4.91e-05	0.0146	CbGeAlD
Rilpivirine—Infection—Triamcinolone—hematologic cancer	4.9e-05	0.000328	CcSEcCtD
Rilpivirine—Insomnia—Prednisolone—hematologic cancer	4.85e-05	0.000325	CcSEcCtD
Rilpivirine—Dizziness—Thalidomide—hematologic cancer	4.84e-05	0.000324	CcSEcCtD
Rilpivirine—Somnolence—Etoposide—hematologic cancer	4.83e-05	0.000324	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Methotrexate—hematologic cancer	4.83e-05	0.000323	CcSEcCtD
Rilpivirine—Nausea—Bortezomib—hematologic cancer	4.82e-05	0.000323	CcSEcCtD
Rilpivirine—Asthenia—Vincristine—hematologic cancer	4.81e-05	0.000322	CcSEcCtD
Rilpivirine—Vomiting—Thiotepa—hematologic cancer	4.81e-05	0.000322	CcSEcCtD
Rilpivirine—Diarrhoea—Carmustine—hematologic cancer	4.81e-05	0.000322	CcSEcCtD
Rilpivirine—Mental disorder—Prednisone—hematologic cancer	4.8e-05	0.000322	CcSEcCtD
Rilpivirine—Nausea—Bleomycin—hematologic cancer	4.78e-05	0.00032	CcSEcCtD
Rilpivirine—Malnutrition—Prednisone—hematologic cancer	4.77e-05	0.00032	CcSEcCtD
Rilpivirine—Rash—Thiotepa—hematologic cancer	4.77e-05	0.000319	CcSEcCtD
Rilpivirine—Dermatitis—Thiotepa—hematologic cancer	4.77e-05	0.000319	CcSEcCtD
Rilpivirine—Diarrhoea—Alitretinoin—hematologic cancer	4.77e-05	0.000319	CcSEcCtD
Rilpivirine—Headache—Thiotepa—hematologic cancer	4.74e-05	0.000317	CcSEcCtD
Rilpivirine—Decreased appetite—Etoposide—hematologic cancer	4.73e-05	0.000316	CcSEcCtD
Rilpivirine—Diarrhoea—Ifosfamide—hematologic cancer	4.71e-05	0.000315	CcSEcCtD
Rilpivirine—Nausea—Vinorelbine—hematologic cancer	4.71e-05	0.000315	CcSEcCtD
Rilpivirine—Renal failure—Epirubicin—hematologic cancer	4.7e-05	0.000314	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Etoposide—hematologic cancer	4.69e-05	0.000314	CcSEcCtD
Rilpivirine—Asthenia—Mitoxantrone—hematologic cancer	4.69e-05	0.000314	CcSEcCtD
Rilpivirine—Asthenia—Irinotecan—hematologic cancer	4.69e-05	0.000314	CcSEcCtD
Rilpivirine—Fatigue—Etoposide—hematologic cancer	4.69e-05	0.000314	CcSEcCtD
Rilpivirine—Vomiting—Thalidomide—hematologic cancer	4.65e-05	0.000312	CcSEcCtD
Rilpivirine—Anxiety—Betamethasone—hematologic cancer	4.65e-05	0.000311	CcSEcCtD
Rilpivirine—Anxiety—Dexamethasone—hematologic cancer	4.65e-05	0.000311	CcSEcCtD
Rilpivirine—Dizziness—Carmustine—hematologic cancer	4.65e-05	0.000311	CcSEcCtD
Rilpivirine—Rash—Thalidomide—hematologic cancer	4.62e-05	0.000309	CcSEcCtD
Rilpivirine—Dermatitis—Thalidomide—hematologic cancer	4.61e-05	0.000309	CcSEcCtD
Rilpivirine—Dizziness—Alitretinoin—hematologic cancer	4.61e-05	0.000308	CcSEcCtD
Rilpivirine—Diarrhoea—Vincristine—hematologic cancer	4.59e-05	0.000307	CcSEcCtD
Rilpivirine—Headache—Thalidomide—hematologic cancer	4.59e-05	0.000307	CcSEcCtD
Rilpivirine—Asthenia—Gemcitabine—hematologic cancer	4.57e-05	0.000306	CcSEcCtD
Rilpivirine—Dizziness—Ifosfamide—hematologic cancer	4.55e-05	0.000305	CcSEcCtD
Rilpivirine—Urinary tract disorder—Methotrexate—hematologic cancer	4.53e-05	0.000303	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Epirubicin—hematologic cancer	4.52e-05	0.000302	CcSEcCtD
Rilpivirine—Nausea—Thiotepa—hematologic cancer	4.5e-05	0.000301	CcSEcCtD
Rilpivirine—Urethral disorder—Methotrexate—hematologic cancer	4.49e-05	0.000301	CcSEcCtD
Rilpivirine—Diarrhoea—Mitoxantrone—hematologic cancer	4.47e-05	0.000299	CcSEcCtD
Rilpivirine—Diarrhoea—Irinotecan—hematologic cancer	4.47e-05	0.000299	CcSEcCtD
Rilpivirine—Vomiting—Carmustine—hematologic cancer	4.47e-05	0.000299	CcSEcCtD
Rilpivirine—Insomnia—Triamcinolone—hematologic cancer	4.46e-05	0.000299	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Etoposide—hematologic cancer	4.45e-05	0.000298	CcSEcCtD
Rilpivirine—Infection—Dexamethasone—hematologic cancer	4.44e-05	0.000298	CcSEcCtD
Rilpivirine—Infection—Betamethasone—hematologic cancer	4.44e-05	0.000298	CcSEcCtD
Rilpivirine—Dizziness—Vincristine—hematologic cancer	4.44e-05	0.000297	CcSEcCtD
Rilpivirine—Rash—Carmustine—hematologic cancer	4.43e-05	0.000297	CcSEcCtD
Rilpivirine—Dermatitis—Carmustine—hematologic cancer	4.43e-05	0.000296	CcSEcCtD
Rilpivirine—Vomiting—Alitretinoin—hematologic cancer	4.43e-05	0.000296	CcSEcCtD
Rilpivirine—Headache—Carmustine—hematologic cancer	4.4e-05	0.000295	CcSEcCtD
Rilpivirine—Rash—Alitretinoin—hematologic cancer	4.39e-05	0.000294	CcSEcCtD
Rilpivirine—Nervous system disorder—Betamethasone—hematologic cancer	4.39e-05	0.000294	CcSEcCtD
Rilpivirine—Nervous system disorder—Dexamethasone—hematologic cancer	4.39e-05	0.000294	CcSEcCtD
Rilpivirine—Dermatitis—Alitretinoin—hematologic cancer	4.39e-05	0.000294	CcSEcCtD
Rilpivirine—Vomiting—Ifosfamide—hematologic cancer	4.38e-05	0.000293	CcSEcCtD
Rilpivirine—Headache—Alitretinoin—hematologic cancer	4.36e-05	0.000292	CcSEcCtD
Rilpivirine—Diarrhoea—Gemcitabine—hematologic cancer	4.36e-05	0.000292	CcSEcCtD
Rilpivirine—Nausea—Thalidomide—hematologic cancer	4.35e-05	0.000291	CcSEcCtD
Rilpivirine—Renal failure—Doxorubicin—hematologic cancer	4.35e-05	0.000291	CcSEcCtD
Rilpivirine—Rash—Ifosfamide—hematologic cancer	4.34e-05	0.000291	CcSEcCtD
Rilpivirine—Dermatitis—Ifosfamide—hematologic cancer	4.34e-05	0.00029	CcSEcCtD
Rilpivirine—Dizziness—Irinotecan—hematologic cancer	4.32e-05	0.000289	CcSEcCtD
Rilpivirine—Abdominal pain—Etoposide—hematologic cancer	4.3e-05	0.000288	CcSEcCtD
Rilpivirine—Vomiting—Vincristine—hematologic cancer	4.27e-05	0.000286	CcSEcCtD
Rilpivirine—Asthenia—Cisplatin—hematologic cancer	4.26e-05	0.000285	CcSEcCtD
Rilpivirine—Fatigue—Triamcinolone—hematologic cancer	4.25e-05	0.000285	CcSEcCtD
Rilpivirine—Urinary tract disorder—Epirubicin—hematologic cancer	4.24e-05	0.000284	CcSEcCtD
Rilpivirine—Rash—Vincristine—hematologic cancer	4.23e-05	0.000283	CcSEcCtD
Rilpivirine—Dermatitis—Vincristine—hematologic cancer	4.23e-05	0.000283	CcSEcCtD
Rilpivirine—Urethral disorder—Epirubicin—hematologic cancer	4.2e-05	0.000281	CcSEcCtD
Rilpivirine—Headache—Vincristine—hematologic cancer	4.2e-05	0.000281	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Doxorubicin—hematologic cancer	4.18e-05	0.00028	CcSEcCtD
Rilpivirine—Nausea—Carmustine—hematologic cancer	4.18e-05	0.00028	CcSEcCtD
Rilpivirine—Vomiting—Mitoxantrone—hematologic cancer	4.16e-05	0.000278	CcSEcCtD
Rilpivirine—Vomiting—Irinotecan—hematologic cancer	4.16e-05	0.000278	CcSEcCtD
Rilpivirine—Immune system disorder—Methotrexate—hematologic cancer	4.14e-05	0.000277	CcSEcCtD
Rilpivirine—Nausea—Alitretinoin—hematologic cancer	4.14e-05	0.000277	CcSEcCtD
Rilpivirine—Rash—Irinotecan—hematologic cancer	4.12e-05	0.000276	CcSEcCtD
Rilpivirine—Rash—Mitoxantrone—hematologic cancer	4.12e-05	0.000276	CcSEcCtD
Rilpivirine—Dermatitis—Mitoxantrone—hematologic cancer	4.12e-05	0.000276	CcSEcCtD
Rilpivirine—Dermatitis—Irinotecan—hematologic cancer	4.12e-05	0.000276	CcSEcCtD
Rilpivirine—Headache—Irinotecan—hematologic cancer	4.09e-05	0.000274	CcSEcCtD
Rilpivirine—Headache—Mitoxantrone—hematologic cancer	4.09e-05	0.000274	CcSEcCtD
Rilpivirine—Nausea—Ifosfamide—hematologic cancer	4.09e-05	0.000274	CcSEcCtD
Rilpivirine—Diarrhoea—Cisplatin—hematologic cancer	4.06e-05	0.000272	CcSEcCtD
Rilpivirine—Anxiety—Prednisone—hematologic cancer	4.05e-05	0.000271	CcSEcCtD
Rilpivirine—Vomiting—Gemcitabine—hematologic cancer	4.05e-05	0.000271	CcSEcCtD
Rilpivirine—Insomnia—Betamethasone—hematologic cancer	4.05e-05	0.000271	CcSEcCtD
Rilpivirine—Insomnia—Dexamethasone—hematologic cancer	4.05e-05	0.000271	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	4.04e-05	0.00027	CcSEcCtD
Rilpivirine—Mental disorder—Methotrexate—hematologic cancer	4.02e-05	0.000269	CcSEcCtD
Rilpivirine—Rash—Gemcitabine—hematologic cancer	4.01e-05	0.000269	CcSEcCtD
Rilpivirine—Dermatitis—Gemcitabine—hematologic cancer	4.01e-05	0.000268	CcSEcCtD
Rilpivirine—Malnutrition—Methotrexate—hematologic cancer	3.99e-05	0.000267	CcSEcCtD
Rilpivirine—Headache—Gemcitabine—hematologic cancer	3.99e-05	0.000267	CcSEcCtD
Rilpivirine—Nausea—Vincristine—hematologic cancer	3.99e-05	0.000267	CcSEcCtD
Rilpivirine—Urinary tract disorder—Doxorubicin—hematologic cancer	3.92e-05	0.000262	CcSEcCtD
Rilpivirine—Asthenia—Etoposide—hematologic cancer	3.9e-05	0.000261	CcSEcCtD
Rilpivirine—Urethral disorder—Doxorubicin—hematologic cancer	3.89e-05	0.00026	CcSEcCtD
Rilpivirine—Decreased appetite—Betamethasone—hematologic cancer	3.89e-05	0.00026	CcSEcCtD
Rilpivirine—Decreased appetite—Dexamethasone—hematologic cancer	3.89e-05	0.00026	CcSEcCtD
Rilpivirine—Nausea—Irinotecan—hematologic cancer	3.88e-05	0.00026	CcSEcCtD
Rilpivirine—Nausea—Mitoxantrone—hematologic cancer	3.88e-05	0.00026	CcSEcCtD
Rilpivirine—Immune system disorder—Epirubicin—hematologic cancer	3.87e-05	0.000259	CcSEcCtD
Rilpivirine—Infection—Prednisone—hematologic cancer	3.87e-05	0.000259	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.86e-05	0.000259	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.86e-05	0.000259	CcSEcCtD
Rilpivirine—Fatigue—Dexamethasone—hematologic cancer	3.86e-05	0.000258	CcSEcCtD
Rilpivirine—Fatigue—Betamethasone—hematologic cancer	3.86e-05	0.000258	CcSEcCtD
Rilpivirine—Nervous system disorder—Prednisone—hematologic cancer	3.82e-05	0.000256	CcSEcCtD
Rilpivirine—Skin disorder—Prednisone—hematologic cancer	3.78e-05	0.000253	CcSEcCtD
Rilpivirine—Nausea—Gemcitabine—hematologic cancer	3.78e-05	0.000253	CcSEcCtD
Rilpivirine—Vomiting—Cisplatin—hematologic cancer	3.77e-05	0.000253	CcSEcCtD
Rilpivirine—Mental disorder—Epirubicin—hematologic cancer	3.76e-05	0.000252	CcSEcCtD
Rilpivirine—Rash—Cisplatin—hematologic cancer	3.74e-05	0.00025	CcSEcCtD
Rilpivirine—Dermatitis—Cisplatin—hematologic cancer	3.74e-05	0.00025	CcSEcCtD
Rilpivirine—Malnutrition—Epirubicin—hematologic cancer	3.73e-05	0.00025	CcSEcCtD
Rilpivirine—Diarrhoea—Etoposide—hematologic cancer	3.72e-05	0.000249	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Betamethasone—hematologic cancer	3.66e-05	0.000245	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.66e-05	0.000245	CcSEcCtD
Rilpivirine—Dizziness—Etoposide—hematologic cancer	3.59e-05	0.000241	CcSEcCtD
Rilpivirine—Immune system disorder—Doxorubicin—hematologic cancer	3.58e-05	0.00024	CcSEcCtD
Rilpivirine—ABCB1—lymph node—hematologic cancer	3.56e-05	0.0106	CbGeAlD
Rilpivirine—Dizziness—Prednisolone—hematologic cancer	3.55e-05	0.000237	CcSEcCtD
Rilpivirine—Asthenia—Triamcinolone—hematologic cancer	3.54e-05	0.000237	CcSEcCtD
Rilpivirine—Abdominal pain—Dexamethasone—hematologic cancer	3.54e-05	0.000237	CcSEcCtD
Rilpivirine—Abdominal pain—Betamethasone—hematologic cancer	3.54e-05	0.000237	CcSEcCtD
Rilpivirine—Nausea—Cisplatin—hematologic cancer	3.52e-05	0.000236	CcSEcCtD
Rilpivirine—Insomnia—Prednisone—hematologic cancer	3.52e-05	0.000236	CcSEcCtD
Rilpivirine—Mental disorder—Doxorubicin—hematologic cancer	3.48e-05	0.000233	CcSEcCtD
Rilpivirine—Vomiting—Etoposide—hematologic cancer	3.46e-05	0.000231	CcSEcCtD
Rilpivirine—Malnutrition—Doxorubicin—hematologic cancer	3.45e-05	0.000231	CcSEcCtD
Rilpivirine—Rash—Etoposide—hematologic cancer	3.43e-05	0.000229	CcSEcCtD
Rilpivirine—Dermatitis—Etoposide—hematologic cancer	3.42e-05	0.000229	CcSEcCtD
Rilpivirine—Headache—Etoposide—hematologic cancer	3.41e-05	0.000228	CcSEcCtD
Rilpivirine—Decreased appetite—Prednisone—hematologic cancer	3.39e-05	0.000227	CcSEcCtD
Rilpivirine—Rash—Prednisolone—hematologic cancer	3.38e-05	0.000226	CcSEcCtD
Rilpivirine—Dermatitis—Prednisolone—hematologic cancer	3.38e-05	0.000226	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.37e-05	0.000226	CcSEcCtD
Rilpivirine—Fatigue—Prednisone—hematologic cancer	3.36e-05	0.000225	CcSEcCtD
Rilpivirine—Headache—Prednisolone—hematologic cancer	3.36e-05	0.000225	CcSEcCtD
Rilpivirine—Dizziness—Triamcinolone—hematologic cancer	3.26e-05	0.000218	CcSEcCtD
Rilpivirine—Infection—Methotrexate—hematologic cancer	3.23e-05	0.000217	CcSEcCtD
Rilpivirine—Nausea—Etoposide—hematologic cancer	3.23e-05	0.000216	CcSEcCtD
Rilpivirine—Asthenia—Betamethasone—hematologic cancer	3.21e-05	0.000215	CcSEcCtD
Rilpivirine—Asthenia—Dexamethasone—hematologic cancer	3.21e-05	0.000215	CcSEcCtD
Rilpivirine—Nervous system disorder—Methotrexate—hematologic cancer	3.19e-05	0.000214	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Prednisone—hematologic cancer	3.19e-05	0.000213	CcSEcCtD
Rilpivirine—Nausea—Prednisolone—hematologic cancer	3.18e-05	0.000213	CcSEcCtD
Rilpivirine—Anxiety—Epirubicin—hematologic cancer	3.17e-05	0.000212	CcSEcCtD
Rilpivirine—Skin disorder—Methotrexate—hematologic cancer	3.16e-05	0.000212	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.16e-05	0.000211	CcSEcCtD
Rilpivirine—Vomiting—Triamcinolone—hematologic cancer	3.14e-05	0.00021	CcSEcCtD
Rilpivirine—Rash—Triamcinolone—hematologic cancer	3.11e-05	0.000208	CcSEcCtD
Rilpivirine—Dry mouth—Epirubicin—hematologic cancer	3.11e-05	0.000208	CcSEcCtD
Rilpivirine—Dermatitis—Triamcinolone—hematologic cancer	3.11e-05	0.000208	CcSEcCtD
Rilpivirine—Headache—Triamcinolone—hematologic cancer	3.09e-05	0.000207	CcSEcCtD
Rilpivirine—Abdominal pain—Prednisone—hematologic cancer	3.08e-05	0.000206	CcSEcCtD
Rilpivirine—Diarrhoea—Betamethasone—hematologic cancer	3.06e-05	0.000205	CcSEcCtD
Rilpivirine—Diarrhoea—Dexamethasone—hematologic cancer	3.06e-05	0.000205	CcSEcCtD
Rilpivirine—Infection—Epirubicin—hematologic cancer	3.03e-05	0.000203	CcSEcCtD
Rilpivirine—Nervous system disorder—Epirubicin—hematologic cancer	2.99e-05	0.0002	CcSEcCtD
Rilpivirine—Skin disorder—Epirubicin—hematologic cancer	2.96e-05	0.000198	CcSEcCtD
Rilpivirine—Dizziness—Dexamethasone—hematologic cancer	2.96e-05	0.000198	CcSEcCtD
Rilpivirine—Dizziness—Betamethasone—hematologic cancer	2.96e-05	0.000198	CcSEcCtD
Rilpivirine—Insomnia—Methotrexate—hematologic cancer	2.95e-05	0.000197	CcSEcCtD
Rilpivirine—Anxiety—Doxorubicin—hematologic cancer	2.93e-05	0.000196	CcSEcCtD
Rilpivirine—Nausea—Triamcinolone—hematologic cancer	2.93e-05	0.000196	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.92e-05	0.000196	CcSEcCtD
Rilpivirine—Somnolence—Methotrexate—hematologic cancer	2.89e-05	0.000194	CcSEcCtD
Rilpivirine—Dry mouth—Doxorubicin—hematologic cancer	2.88e-05	0.000193	CcSEcCtD
Rilpivirine—Vomiting—Betamethasone—hematologic cancer	2.84e-05	0.00019	CcSEcCtD
Rilpivirine—Vomiting—Dexamethasone—hematologic cancer	2.84e-05	0.00019	CcSEcCtD
Rilpivirine—Decreased appetite—Methotrexate—hematologic cancer	2.83e-05	0.000189	CcSEcCtD
Rilpivirine—Rash—Dexamethasone—hematologic cancer	2.82e-05	0.000189	CcSEcCtD
Rilpivirine—Rash—Betamethasone—hematologic cancer	2.82e-05	0.000189	CcSEcCtD
Rilpivirine—Dermatitis—Betamethasone—hematologic cancer	2.82e-05	0.000189	CcSEcCtD
Rilpivirine—Dermatitis—Dexamethasone—hematologic cancer	2.82e-05	0.000189	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.81e-05	0.000188	CcSEcCtD
Rilpivirine—Fatigue—Methotrexate—hematologic cancer	2.81e-05	0.000188	CcSEcCtD
Rilpivirine—Headache—Dexamethasone—hematologic cancer	2.8e-05	0.000188	CcSEcCtD
Rilpivirine—Headache—Betamethasone—hematologic cancer	2.8e-05	0.000188	CcSEcCtD
Rilpivirine—Infection—Doxorubicin—hematologic cancer	2.8e-05	0.000188	CcSEcCtD
Rilpivirine—Asthenia—Prednisone—hematologic cancer	2.8e-05	0.000187	CcSEcCtD
Rilpivirine—Nervous system disorder—Doxorubicin—hematologic cancer	2.77e-05	0.000185	CcSEcCtD
Rilpivirine—Insomnia—Epirubicin—hematologic cancer	2.76e-05	0.000184	CcSEcCtD
Rilpivirine—Skin disorder—Doxorubicin—hematologic cancer	2.74e-05	0.000183	CcSEcCtD
Rilpivirine—Somnolence—Epirubicin—hematologic cancer	2.71e-05	0.000181	CcSEcCtD
Rilpivirine—Diarrhoea—Prednisone—hematologic cancer	2.67e-05	0.000178	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Methotrexate—hematologic cancer	2.66e-05	0.000178	CcSEcCtD
Rilpivirine—Nausea—Betamethasone—hematologic cancer	2.66e-05	0.000178	CcSEcCtD
Rilpivirine—Nausea—Dexamethasone—hematologic cancer	2.66e-05	0.000178	CcSEcCtD
Rilpivirine—Decreased appetite—Epirubicin—hematologic cancer	2.65e-05	0.000177	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.63e-05	0.000176	CcSEcCtD
Rilpivirine—Fatigue—Epirubicin—hematologic cancer	2.63e-05	0.000176	CcSEcCtD
Rilpivirine—Dizziness—Prednisone—hematologic cancer	2.58e-05	0.000172	CcSEcCtD
Rilpivirine—Abdominal pain—Methotrexate—hematologic cancer	2.57e-05	0.000172	CcSEcCtD
Rilpivirine—Insomnia—Doxorubicin—hematologic cancer	2.55e-05	0.000171	CcSEcCtD
Rilpivirine—Somnolence—Doxorubicin—hematologic cancer	2.51e-05	0.000168	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Epirubicin—hematologic cancer	2.49e-05	0.000167	CcSEcCtD
Rilpivirine—Vomiting—Prednisone—hematologic cancer	2.48e-05	0.000166	CcSEcCtD
Rilpivirine—Rash—Prednisone—hematologic cancer	2.46e-05	0.000164	CcSEcCtD
Rilpivirine—Dermatitis—Prednisone—hematologic cancer	2.45e-05	0.000164	CcSEcCtD
Rilpivirine—Decreased appetite—Doxorubicin—hematologic cancer	2.45e-05	0.000164	CcSEcCtD
Rilpivirine—Headache—Prednisone—hematologic cancer	2.44e-05	0.000163	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.43e-05	0.000163	CcSEcCtD
Rilpivirine—Fatigue—Doxorubicin—hematologic cancer	2.43e-05	0.000163	CcSEcCtD
Rilpivirine—Abdominal pain—Epirubicin—hematologic cancer	2.41e-05	0.000161	CcSEcCtD
Rilpivirine—Asthenia—Methotrexate—hematologic cancer	2.34e-05	0.000156	CcSEcCtD
Rilpivirine—Nausea—Prednisone—hematologic cancer	2.31e-05	0.000155	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.31e-05	0.000154	CcSEcCtD
Rilpivirine—Abdominal pain—Doxorubicin—hematologic cancer	2.23e-05	0.000149	CcSEcCtD
Rilpivirine—Diarrhoea—Methotrexate—hematologic cancer	2.23e-05	0.000149	CcSEcCtD
Rilpivirine—Asthenia—Epirubicin—hematologic cancer	2.19e-05	0.000146	CcSEcCtD
Rilpivirine—Dizziness—Methotrexate—hematologic cancer	2.15e-05	0.000144	CcSEcCtD
Rilpivirine—Diarrhoea—Epirubicin—hematologic cancer	2.08e-05	0.00014	CcSEcCtD
Rilpivirine—Vomiting—Methotrexate—hematologic cancer	2.07e-05	0.000139	CcSEcCtD
Rilpivirine—Rash—Methotrexate—hematologic cancer	2.05e-05	0.000137	CcSEcCtD
Rilpivirine—Dermatitis—Methotrexate—hematologic cancer	2.05e-05	0.000137	CcSEcCtD
Rilpivirine—Headache—Methotrexate—hematologic cancer	2.04e-05	0.000137	CcSEcCtD
Rilpivirine—Asthenia—Doxorubicin—hematologic cancer	2.02e-05	0.000135	CcSEcCtD
Rilpivirine—Dizziness—Epirubicin—hematologic cancer	2.02e-05	0.000135	CcSEcCtD
Rilpivirine—Vomiting—Epirubicin—hematologic cancer	1.94e-05	0.00013	CcSEcCtD
Rilpivirine—Nausea—Methotrexate—hematologic cancer	1.93e-05	0.000129	CcSEcCtD
Rilpivirine—Diarrhoea—Doxorubicin—hematologic cancer	1.93e-05	0.000129	CcSEcCtD
Rilpivirine—Rash—Epirubicin—hematologic cancer	1.92e-05	0.000129	CcSEcCtD
Rilpivirine—Dermatitis—Epirubicin—hematologic cancer	1.92e-05	0.000128	CcSEcCtD
Rilpivirine—Headache—Epirubicin—hematologic cancer	1.91e-05	0.000128	CcSEcCtD
Rilpivirine—Dizziness—Doxorubicin—hematologic cancer	1.86e-05	0.000125	CcSEcCtD
Rilpivirine—Nausea—Epirubicin—hematologic cancer	1.81e-05	0.000121	CcSEcCtD
Rilpivirine—Vomiting—Doxorubicin—hematologic cancer	1.79e-05	0.00012	CcSEcCtD
Rilpivirine—Rash—Doxorubicin—hematologic cancer	1.78e-05	0.000119	CcSEcCtD
Rilpivirine—Dermatitis—Doxorubicin—hematologic cancer	1.78e-05	0.000119	CcSEcCtD
Rilpivirine—Headache—Doxorubicin—hematologic cancer	1.77e-05	0.000118	CcSEcCtD
Rilpivirine—Nausea—Doxorubicin—hematologic cancer	1.67e-05	0.000112	CcSEcCtD
Rilpivirine—CYP2C19—Metabolism—TXN—hematologic cancer	6e-06	0.000109	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTO1—hematologic cancer	6e-06	0.000109	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ABCB1—hematologic cancer	5.95e-06	0.000108	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—IDH1—hematologic cancer	5.92e-06	0.000108	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CREBBP—hematologic cancer	5.92e-06	0.000108	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	5.92e-06	0.000108	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—FHL2—hematologic cancer	5.92e-06	0.000108	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	5.87e-06	0.000107	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—SPHK1—hematologic cancer	5.87e-06	0.000107	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ABCC3—hematologic cancer	5.86e-06	0.000107	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—TXN—hematologic cancer	5.86e-06	0.000107	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTO1—hematologic cancer	5.86e-06	0.000107	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GSTP1—hematologic cancer	5.82e-06	0.000106	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—AGRN—hematologic cancer	5.8e-06	0.000105	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PC—hematologic cancer	5.8e-06	0.000105	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—GSTM1—hematologic cancer	5.78e-06	0.000105	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—NCOR1—hematologic cancer	5.78e-06	0.000105	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—SPHK1—hematologic cancer	5.73e-06	0.000104	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—UGT1A1—hematologic cancer	5.64e-06	0.000103	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—AKT1—hematologic cancer	5.62e-06	0.000102	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PIK3CD—hematologic cancer	5.61e-06	0.000102	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GBA—hematologic cancer	5.6e-06	0.000102	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	5.6e-06	0.000102	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—ALB—hematologic cancer	5.54e-06	0.000101	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ABCB1—hematologic cancer	5.51e-06	0.0001	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—UGT1A1—hematologic cancer	5.51e-06	0.0001	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—IDH2—hematologic cancer	5.5e-06	0.0001	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—HMMR—hematologic cancer	5.5e-06	0.0001	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—SLC22A1—hematologic cancer	5.49e-06	9.98e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CRABP1—hematologic cancer	5.49e-06	9.98e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	5.4e-06	9.81e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—SLC22A1—hematologic cancer	5.36e-06	9.74e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CRABP1—hematologic cancer	5.36e-06	9.74e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—NCOR1—hematologic cancer	5.35e-06	9.73e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GSTM1—hematologic cancer	5.35e-06	9.73e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ALOX5—hematologic cancer	5.35e-06	9.73e-05	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PIK3R1—hematologic cancer	5.3e-06	9.64e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ALOX5—hematologic cancer	5.22e-06	9.49e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	5.22e-06	9.49e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	5.19e-06	9.43e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—NUP98—hematologic cancer	5.18e-06	9.42e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ARNTL—hematologic cancer	5.17e-06	9.4e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—MTAP—hematologic cancer	5.12e-06	9.31e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—NQO1—hematologic cancer	5.12e-06	9.31e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CD44—hematologic cancer	5.12e-06	9.31e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—MTHFR—hematologic cancer	5.11e-06	9.29e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—NUP98—hematologic cancer	5.06e-06	9.19e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CA9—hematologic cancer	5.03e-06	9.15e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ACP5—hematologic cancer	5.03e-06	9.15e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ADCY7—hematologic cancer	5.03e-06	9.14e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—NCOA3—hematologic cancer	5.03e-06	9.14e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—NUP214—hematologic cancer	4.99e-06	9.08e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NCOR2—hematologic cancer	4.96e-06	9.03e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.94e-06	8.99e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ADCY7—hematologic cancer	4.91e-06	8.93e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—NCOA3—hematologic cancer	4.91e-06	8.93e-05	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PIK3CB—hematologic cancer	4.89e-06	8.9e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ABCG2—hematologic cancer	4.89e-06	8.9e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—MTR—hematologic cancer	4.89e-06	8.9e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—NUP214—hematologic cancer	4.87e-06	8.86e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CYCS—hematologic cancer	4.84e-06	8.81e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—HSP90AA1—hematologic cancer	4.81e-06	8.75e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ENO2—hematologic cancer	4.8e-06	8.72e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—MTR—hematologic cancer	4.78e-06	8.68e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ABCG2—hematologic cancer	4.78e-06	8.68e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—IDH1—hematologic cancer	4.73e-06	8.6e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—MTHFR—hematologic cancer	4.73e-06	8.6e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ENO2—hematologic cancer	4.68e-06	8.51e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTO1—hematologic cancer	4.68e-06	8.5e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—TXN—hematologic cancer	4.68e-06	8.5e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ABCC3—hematologic cancer	4.68e-06	8.5e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTT1—hematologic cancer	4.65e-06	8.46e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.58e-06	8.33e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—SPHK1—hematologic cancer	4.58e-06	8.32e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—FHL2—hematologic cancer	4.57e-06	8.3e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—SDC1—hematologic cancer	4.55e-06	8.27e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTT1—hematologic cancer	4.54e-06	8.26e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.5e-06	8.18e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—AGRN—hematologic cancer	4.48e-06	8.14e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—SDC1—hematologic cancer	4.44e-06	8.07e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	4.41e-06	8.01e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—UGT1A1—hematologic cancer	4.4e-06	7.99e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.34e-06	7.9e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	4.29e-06	7.8e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.29e-06	7.8e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—SLC22A1—hematologic cancer	4.28e-06	7.78e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CRABP1—hematologic cancer	4.28e-06	7.78e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GSTP1—hematologic cancer	4.27e-06	7.76e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.25e-06	7.73e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—IDH2—hematologic cancer	4.24e-06	7.72e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—HMMR—hematologic cancer	4.24e-06	7.72e-05	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PTEN—hematologic cancer	4.23e-06	7.69e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ALOX5—hematologic cancer	4.17e-06	7.58e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.1e-06	7.46e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ABCB1—hematologic cancer	4.04e-06	7.35e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NUP98—hematologic cancer	4.04e-06	7.34e-05	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—EP300—hematologic cancer	4.03e-06	7.33e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.99e-06	7.26e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.98e-06	7.24e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CREBBP—hematologic cancer	3.98e-06	7.23e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3CG—hematologic cancer	3.97e-06	7.22e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GSTM1—hematologic cancer	3.92e-06	7.13e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—NCOR1—hematologic cancer	3.92e-06	7.13e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NCOA3—hematologic cancer	3.92e-06	7.13e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ADCY7—hematologic cancer	3.92e-06	7.13e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NUP214—hematologic cancer	3.89e-06	7.07e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CA9—hematologic cancer	3.88e-06	7.06e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ACP5—hematologic cancer	3.88e-06	7.06e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—NQO1—hematologic cancer	3.87e-06	7.03e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CD44—hematologic cancer	3.87e-06	7.03e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.85e-06	7e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.83e-06	6.97e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—MTR—hematologic cancer	3.81e-06	6.93e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ABCG2—hematologic cancer	3.81e-06	6.93e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.79e-06	6.89e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CD44—hematologic cancer	3.77e-06	6.86e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—NQO1—hematologic cancer	3.77e-06	6.86e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	3.77e-06	6.86e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ENO2—hematologic cancer	3.74e-06	6.8e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ALB—hematologic cancer	3.72e-06	6.77e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CREBBP—hematologic cancer	3.68e-06	6.7e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CYCS—hematologic cancer	3.66e-06	6.65e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—IDH1—hematologic cancer	3.65e-06	6.64e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	3.64e-06	6.61e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.63e-06	6.59e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—TXN—hematologic cancer	3.61e-06	6.56e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.61e-06	6.56e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.61e-06	6.56e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CYCS—hematologic cancer	3.57e-06	6.49e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.57e-06	6.49e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	3.56e-06	6.48e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—HSP90AA1—hematologic cancer	3.55e-06	6.45e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—SDC1—hematologic cancer	3.54e-06	6.44e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.53e-06	6.42e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3CD—hematologic cancer	3.49e-06	6.35e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—MTHFR—hematologic cancer	3.47e-06	6.3e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ALB—hematologic cancer	3.45e-06	6.27e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.39e-06	6.17e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.39e-06	6.16e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.34e-06	6.08e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.3e-06	6e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.3e-06	6e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3R1—hematologic cancer	3.3e-06	6e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	3.29e-06	5.98e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.27e-06	5.95e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTP1—hematologic cancer	3.23e-06	5.86e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.22e-06	5.85e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.2e-06	5.81e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTP1—hematologic cancer	3.15e-06	5.72e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.12e-06	5.67e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NUP98—hematologic cancer	3.12e-06	5.66e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ABCB1—hematologic cancer	3.05e-06	5.55e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3CB—hematologic cancer	3.04e-06	5.54e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.02e-06	5.5e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.02e-06	5.5e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NQO1—hematologic cancer	3.01e-06	5.48e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CD44—hematologic cancer	3.01e-06	5.48e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NUP214—hematologic cancer	3e-06	5.46e-05	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PIK3CA—hematologic cancer	2.98e-06	5.42e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.96e-06	5.39e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.96e-06	5.39e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.95e-06	5.37e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—MTR—hematologic cancer	2.94e-06	5.35e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.94e-06	5.35e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3CG—hematologic cancer	2.91e-06	5.3e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTM1—hematologic cancer	2.89e-06	5.26e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—NCOR1—hematologic cancer	2.89e-06	5.26e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ENO2—hematologic cancer	2.89e-06	5.25e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CYCS—hematologic cancer	2.85e-06	5.18e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PTEN—hematologic cancer	2.84e-06	5.17e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.83e-06	5.15e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.8e-06	5.09e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SDC1—hematologic cancer	2.74e-06	4.97e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—EP300—hematologic cancer	2.71e-06	4.93e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CREBBP—hematologic cancer	2.7e-06	4.91e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PTEN—hematologic cancer	2.63e-06	4.78e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.62e-06	4.76e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3CD—hematologic cancer	2.56e-06	4.66e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—MTHFR—hematologic cancer	2.56e-06	4.65e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.55e-06	4.64e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ALB—hematologic cancer	2.53e-06	4.6e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.51e-06	4.57e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—EP300—hematologic cancer	2.51e-06	4.56e-05	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—AKT1—hematologic cancer	2.44e-06	4.43e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.43e-06	4.42e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3R1—hematologic cancer	2.42e-06	4.4e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.38e-06	4.33e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NQO1—hematologic cancer	2.33e-06	4.23e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CD44—hematologic cancer	2.33e-06	4.23e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.31e-06	4.2e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.31e-06	4.2e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.31e-06	4.2e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3CB—hematologic cancer	2.23e-06	4.06e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.2e-06	4e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CYCS—hematologic cancer	2.2e-06	4e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.19e-06	3.98e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.15e-06	3.91e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.04e-06	3.71e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.04e-06	3.71e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	2e-06	3.64e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CREBBP—hematologic cancer	1.99e-06	3.62e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.94e-06	3.53e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.93e-06	3.52e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PTEN—hematologic cancer	1.93e-06	3.51e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ALB—hematologic cancer	1.91e-06	3.47e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.89e-06	3.43e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ALB—hematologic cancer	1.86e-06	3.39e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3CA—hematologic cancer	1.86e-06	3.37e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—EP300—hematologic cancer	1.84e-06	3.34e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.84e-06	3.34e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.83e-06	3.32e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.8e-06	3.27e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.78e-06	3.24e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.78e-06	3.24e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.78e-06	3.24e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.71e-06	3.12e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.69e-06	3.07e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.65e-06	2.99e-05	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—AKT1—hematologic cancer	1.64e-06	2.98e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.59e-06	2.89e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.58e-06	2.86e-05	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—AKT1—hematologic cancer	1.52e-06	2.76e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.51e-06	2.74e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ALB—hematologic cancer	1.49e-06	2.71e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PTEN—hematologic cancer	1.46e-06	2.65e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.42e-06	2.59e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PTEN—hematologic cancer	1.42e-06	2.59e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—EP300—hematologic cancer	1.39e-06	2.53e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.36e-06	2.47e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—EP300—hematologic cancer	1.36e-06	2.47e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.32e-06	2.41e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.31e-06	2.39e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.23e-06	2.23e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.16e-06	2.12e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ALB—hematologic cancer	1.15e-06	2.09e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PTEN—hematologic cancer	1.14e-06	2.06e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—AKT1—hematologic cancer	1.11e-06	2.02e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.1e-06	2e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—EP300—hematologic cancer	1.08e-06	1.97e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.03e-06	1.87e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.01e-06	1.84e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3CA—hematologic cancer	1e-06	1.82e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PTEN—hematologic cancer	8.76e-07	1.59e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—AKT1—hematologic cancer	8.4e-07	1.53e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—EP300—hematologic cancer	8.36e-07	1.52e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—AKT1—hematologic cancer	8.2e-07	1.49e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	8.01e-07	1.46e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—AKT1—hematologic cancer	6.54e-07	1.19e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.18e-07	1.12e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—AKT1—hematologic cancer	5.05e-07	9.18e-06	CbGpPWpGaD
